Lilly(LLY) - 2024 Q2 - Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q2 2024 Results Conference Call August 8, 2024 11:30 AM ET Company Participants Joe Fletcher - Senior Vice President-Investor Relations Dave Ricks - Chief Executive Officer Gordon Brooks - Group VP, Controller & Corporate Strategy and Interim CFO Dan Skovronsky - Chief Scientific Officer and President-Lilly Immunology Patrik Jonsson - President-Lilly Diabetes and Obesity and Lilly USA Ilya Yuffa - Executive Vice President Conference Call Participants Seamus Fernandez - Gugge ...